GeneDx【WGS】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

75.67

買値

74.70

売値

77.00

出来高

418,862

74.74 日の範囲 79.99

3.26 52 週間の範囲 98.87

時価総額

2.079B

前日終値

79.24

始値

78.48

時刻

75.01

最終取引時間

財務取引量

US$ 32,173,542

VWAP

76.8118

平均取引量 (3 か月)

652,165

発行済株式数

27,471,397

配当利回り

PER

-11.82

1 株当たり利益 (EPS)

-6.4

歳入

202.57M

純利益

-175.77M

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and... GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut. 詳細を表示

セクター

Blank Checks

業界

Health Services

ウェブサイト

www.genedx.com

本社

Wilmington, Delaware, USA

設立

2020

GeneDx Holdings Corporation is listed in the Blank Checks sector of the ナスダック市場 with ticker WGS. The last closing price for GeneDx was US$79.24. Over the last year, GeneDx shares have traded in a share price range of US$ 3.26 to US$ 98.87.

GeneDx currently has 27,471,397 shares in issue. The market capitalisation of GeneDx is US$2.18 billion. GeneDx has a price to earnings ratio (PE ratio) of -11.82.

GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced it will release financial results for the fourth quarter 2024 and the full year 2024...

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that, effective as of January 14, 2025, the compensation committee...

GeneDx Announces Preliminary 2024 Financial Results

Expects to exceed guidance with full year 2024 revenues1 of at least $299 million Expects fourth quarter 2024 revenues1 of at least $92 million Expects to exceed guidance with full year 2024...

GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a new way to provide genetic counseling and test-ordering services for patients and...

GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients

Contributed nearly one quarter of all submissions to GeneMatcher and collaborated on more than 85 peer reviewed publications in 2024 GeneDx (Nasdaq: WGS), a leader in delivering improved health...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.51	0.678552421501	75.16	81.8857	73.5	739795	77.35176043	CS
4	-1.14	-1.48418174717	76.81	98.87	66.8076	938295	80.70076491	CS
12	-1.037	-1.35189748002	76.707	98.87	66	652165	78.02098437	CS
26	42.13	125.611210495	33.54	98.87	25.84	587362	63.31870506	CS
52	72.22	2093.33333333	3.45	98.87	3.26	489211	45.78892672	CS
156	64.747	592.758399707	10.923	98.87	1.16	939903	20.50704519	CS
260	64.747	592.758399707	10.923	98.87	1.16	939903	20.50704519	CS

WGS - Frequently Asked Questions (FAQ)

What is the current GeneDx share price?

The current share price of GeneDx is US$ 75.67

How many GeneDx shares are in issue?

GeneDx has 27,471,397 shares in issue

What is the market cap of GeneDx?

The market capitalisation of GeneDx is USD 2.18B

What is the 1 year trading range for GeneDx share price?

GeneDx has traded in the range of US$ 3.26 to US$ 98.87 during the past year

What is the PE ratio of GeneDx?

The price to earnings ratio of GeneDx is -11.82

What is the cash to sales ratio of GeneDx?

The cash to sales ratio of GeneDx is 10.26

What is the reporting currency for GeneDx?

GeneDx reports financial results in USD

What is the latest annual turnover for GeneDx?

The latest annual turnover of GeneDx is USD 202.57M

What is the latest annual profit for GeneDx?

The latest annual profit of GeneDx is USD -175.77M

What is the registered address of GeneDx?

The registered address for GeneDx is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the GeneDx website address?

The website address for GeneDx is www.genedx.com

Which industry sector does GeneDx operate in?

GeneDx operates in the HEALTH SERVICES sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
DGNXDiginex Ltd	US$ 49.18 (228.09%)	3.34M
SLXNSilexion Therapeutics Corporation	US$ 3.1301 (131.86%)	330.45M
KRKR36Kr Holdings Inc	US$ 9.10 (114.12%)	23.61M
SPGCSacks Parente Golf Inc	US$ 0.6001 (57.92%)	52.17M
XFORX4 Pharmaceuticals Inc	US$ 0.7542 (56.54%)	42.5M
ZKINZK International Group Co Ltd	US$ 0.4813 (-41.21%)	3.1M
MGOLMGO Global Inc	US$ 0.1019 (-38.73%)	70.52M
BACKIMAC Holdings Inc	US$ 0.7869 (-35.50%)	2.37M
EYENEyenovia Inc	US$ 0.03695 (-35.18%)	25.31M
HAOHaoxi Health Technology Ltd	US$ 2.52 (-31.89%)	484.94k
NVDANVIDIA Corporation	US$ 123.70 (-4.10%)	466.94M
SLXNSilexion Therapeutics Corporation	US$ 3.1301 (131.86%)	330.45M
OCEAOcean Biomedical Inc	US$ 0.249929 (-24.26%)	186.52M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.428 (-6.98%)	148.12M
RIMEAlgorhythm Holdings Inc	US$ 0.0259 (-16.18%)	138.96M